IP Library Patent Application 14847150
Patent Application
App. No. 14/847,150

5-POSITION MODIFIED PYRIMIDINES AND THEIR USE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/847,150
Abstract

The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.

Claims (25)

1 . A C-5 modified aminocarbonylpyrimidine having the following structure:

wherein

R′ is selected from the group consisting of —H, —Ac, -Bz, —CH 2 CH 2 OCH 3 , —C(O)CH 2 OCH 3 and —SiMe 2 tBu;

R″ is selected from the group consisting of H, DMT and triphosphate (—P(O)(OH)—O—P(O)(OH)—O—P(O)(OH) 2 ) or a salt thereof;

X is selected from the group consisting of —H, —OH, —OMe, —O-allyl, —F, —OEt, —OPr, —OCH 2 CH 2 OCH 3 and -azido;

R is selected from the group consisting of —(CH 2 ) n —R X1 ;

R X1 is selected from the group consisting of:

R X4 is selected from the group consisting of a Cl and a nitrile (CN); and

n=0-10.

2 . A 3′-phosporamidite of a C-5 modified aminocarbonylpyrimidine having the following structure:

wherein

R″ is selected from the group consisting of H, DMT and triphosphate (—P(O)(OH)—O—P(O)(OH)—O—P(O)(OH) 2 ) or a salt thereof;

X is selected from the group consisting of —H, —OH, —OMe, —O-allyl, —F, —OEt, —OPr, —OCH 2 CH 2 OCH 3 and -azido;

R is selected from the group consisting of —(CH 2 ) n —R X1 ;

R X1 is selected from the group consisting of:

R X4 selected from the group consisting of a Cl and a nitrile (CN); and

n=0-10.

3 . A 5′-triphosphate of a C-5 modified aminocarbonylpyrimidine having the following structure:

wherein

R′ is selected from the group consisting of —H, —Ac, -Bz, —CH 2 CH 2 OCH 3 , —C(O)CH 2 OCH 3 and —SiMe 2 tBu;

X is selected from the group consisting of —H, —OH, —OMe, —O-allyl, —F, —OEt, —OPr, —OCH 2 CH 2 OCH 3 and -azido;

R is selected from the group consisting of —(CH 2 ) n —R X1 ;

R X1 is selected from the group consisting of:

R X4 selected from the group consisting of a Cl and a nitrile (CN); and

n=0-10.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 20, 2021
From: MADRYN HEALTH PARTNERS, LP, FORMERLY VISIUM HEALTHCARE PARTNERS, LP
To: SOMALOGIC, INC.
Reel/Frame 055981/0884 →
CHANGE OF NAME Recorded Mar 8, 2017
From: VISIUM HEALTHCARE PARTNERS, LP
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 041920/0957 →
SECURITY INTEREST Recorded Feb 29, 2016
From: SOMALOGIC, INC.
To: VISIUM HEALTHCARE PARTNERS, LP
Reel/Frame 037853/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2015
From: ROHLOFF, JOHN; JANJIC, NEBOJSA; CARTER, JEFFREY D.; FOWLER, CATHERINE
To: SOMALOGIC, INC.
Reel/Frame 036511/0888 →